Walmart Inc. (BVMF:WALM34)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions BRL. Fiscal year is February - January.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Market Capitalization	4,362,881	4,606,120	2,195,229	1,975,095	2,052,749	2,175,284
Market Cap Growth	77.82%	109.82%	11.14%	-3.78%	-5.63%	56.41%
Enterprise Value	4,730,549	4,955,926	2,521,786	2,303,719	2,321,903	2,508,828
Last Close Price	34.00	35.97	16.79	14.83	14.97	15.46
PE Ratio	40.98	40.57	28.68	33.22	28.36	29.42
PS Ratio	1.13	1.16	0.69	0.64	0.68	0.71
PB Ratio	8.51	8.07	4.91	4.62	4.22	4.54
P/TBV Ratio	14.04	13.66	8.61	8.77	7.84	8.45
P/FCF Ratio	-	62.29	29.42	32.38	35.02	15.40
P/OCF Ratio	-	21.64	12.45	13.45	16.04	11.02
EV/Sales Ratio	1.24	1.25	0.79	0.74	0.77	0.82
EV/EBITDA Ratio	18.41	20.10	13.15	12.76	11.99	13.60
EV/EBIT Ratio	28.85	29.01	18.92	18.45	16.91	20.33
EV/FCF Ratio	61.89	67.02	33.80	37.76	39.61	17.76
Debt / Equity Ratio	0.76	0.64	0.70	0.73	0.64	0.73
Debt / EBITDA Ratio	1.48	1.36	1.50	1.58	1.47	1.72
Debt / FCF Ratio	5.08	4.91	4.18	5.09	5.28	2.47
Asset Turnover	2.65	2.65	2.62	2.51	2.30	2.29
Inventory Turnover	9.12	9.19	8.79	8.20	8.46	9.40
Quick Ratio	0.19	0.20	0.20	0.18	0.26	0.26
Current Ratio	0.78	0.82	0.83	0.82	0.93	0.97
Return on Equity (ROE)	21.78%	21.41%	18.64%	12.84%	15.54%	16.21%
Return on Assets (ROA)	7.15%	7.12%	6.81%	6.28%	6.52%	5.76%
Return on Capital (ROIC)	11.75%	11.66%	11.30%	10.38%	10.76%	9.21%
Return on Capital Employed (ROCE)	18.50%	17.80%	16.90%	16.20%	16.50%	14.10%
Earnings Yield	2.44%	2.46%	3.49%	3.01%	3.53%	3.40%
FCF Yield	1.75%	1.60%	3.40%	3.09%	2.86%	6.49%
Dividend Yield	0.64%	13.48%	22.34%	25.63%	25.93%	25.49%
Payout Ratio	36.65%	34.41%	39.59%	52.35%	44.99%	45.27%
Buyback Yield / Dilution	0.35%	0.33%	1.15%	2.53%	1.47%	0.73%
Total Shareholder Return	0.99%	13.81%	23.49%	28.16%	27.40%	26.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.